Matches in Wikidata for { <http://www.wikidata.org/entity/Q74068677> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q74068677 description "article scientifique publié en 2000" @default.
- Q74068677 description "artículu científicu espublizáu en xunetu de 2000" @default.
- Q74068677 description "im Juli 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q74068677 description "scientific article published on 01 July 2000" @default.
- Q74068677 description "wetenschappelijk artikel" @default.
- Q74068677 description "наукова стаття, опублікована в липні 2000" @default.
- Q74068677 name "The design and synthesis of thrombin inhibitors: the introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors" @default.
- Q74068677 name "The design and synthesis of thrombin inhibitors: the introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors" @default.
- Q74068677 type Item @default.
- Q74068677 label "The design and synthesis of thrombin inhibitors: the introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors" @default.
- Q74068677 label "The design and synthesis of thrombin inhibitors: the introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors" @default.
- Q74068677 prefLabel "The design and synthesis of thrombin inhibitors: the introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors" @default.
- Q74068677 prefLabel "The design and synthesis of thrombin inhibitors: the introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors" @default.
- Q74068677 P1433 Q74068677-246AF53C-8DE4-47E6-A554-DD626D2E8D71 @default.
- Q74068677 P1476 Q74068677-83A0F5F1-3669-4172-9E21-D60B1D6061FE @default.
- Q74068677 P2093 Q74068677-051C319B-3DBA-4E94-ABC8-04A74E0E0391 @default.
- Q74068677 P2093 Q74068677-1CD07A6C-4DD3-452B-BE36-410F838F79D5 @default.
- Q74068677 P2093 Q74068677-1FBADCFD-B279-4A6A-83AB-2213D3F4AE15 @default.
- Q74068677 P2093 Q74068677-39907E6F-745C-4F47-B515-BE9F948C0070 @default.
- Q74068677 P2093 Q74068677-48F4283A-5560-4F61-868C-798ADF95391C @default.
- Q74068677 P2093 Q74068677-5C8D3787-14E1-4B1F-9225-A218DC3BC206 @default.
- Q74068677 P2093 Q74068677-61285ADF-CCA7-4784-A0F8-04C4FDB94E1A @default.
- Q74068677 P2093 Q74068677-6A3A673E-D0D8-4A68-8D72-47599C6A0641 @default.
- Q74068677 P2093 Q74068677-6BF50F33-3565-404B-898F-00D1451F0DD5 @default.
- Q74068677 P2093 Q74068677-74E3D4F0-C26E-44D2-8DA6-F40A65367DBA @default.
- Q74068677 P2093 Q74068677-8C7F6C48-7318-4C4D-8951-5D4F708964F0 @default.
- Q74068677 P2093 Q74068677-997DCFEF-26BD-4691-A77B-5A63A7056FCF @default.
- Q74068677 P2093 Q74068677-B747BBE2-347F-4E86-B094-459884E3642B @default.
- Q74068677 P2093 Q74068677-BA376E7F-2B06-43C2-8614-DF782926A6D9 @default.
- Q74068677 P2093 Q74068677-C4262F3E-1DE0-4C39-916E-23D99C715660 @default.
- Q74068677 P2860 Q74068677-62B94C59-269C-41A1-B821-6AC95016E381 @default.
- Q74068677 P2860 Q74068677-793EDE9B-E85D-48F0-AC20-5484F978744B @default.
- Q74068677 P2860 Q74068677-E8AF058E-D63B-4186-8C95-C84FF7A92040 @default.
- Q74068677 P304 Q74068677-0F050B84-4748-4C0A-AC57-75C06D9F755F @default.
- Q74068677 P31 Q74068677-F885577A-B6DB-4696-BE32-3F40F0C21018 @default.
- Q74068677 P356 Q74068677-E440A3AF-8DDD-4F8C-A241-E5675ECB360F @default.
- Q74068677 P407 Q74068677-A5192EAB-BDEF-4623-9461-64CC51E8D2D2 @default.
- Q74068677 P433 Q74068677-767F7345-ABCE-4363-8A39-A65F9F284392 @default.
- Q74068677 P478 Q74068677-4007D061-FFF3-4466-BE97-1D285C3D2319 @default.
- Q74068677 P577 Q74068677-C7B75252-4BCF-41AC-9F25-2E21E0C66BD6 @default.
- Q74068677 P698 Q74068677-56A9E9D0-FDDB-44D6-8F56-AC666C970F83 @default.
- Q74068677 P921 Q74068677-30176F4C-300D-45B9-9AC0-FCDE79F8443C @default.
- Q74068677 P356 S0960-894X(00)00283-3 @default.
- Q74068677 P698 10915052 @default.
- Q74068677 P1433 Q2709483 @default.
- Q74068677 P1476 "The design and synthesis of thrombin inhibitors: the introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors" @default.
- Q74068677 P2093 "A Mitchelson" @default.
- Q74068677 P2093 "D LeGrand" @default.
- Q74068677 P2093 "F Lugrin" @default.
- Q74068677 P2093 "J Ambler" @default.
- Q74068677 P2093 "J Hayler" @default.
- Q74068677 P2093 "K Butler" @default.
- Q74068677 P2093 "K Dunnet" @default.
- Q74068677 P2093 "K Menear" @default.
- Q74068677 P2093 "M Allen" @default.
- Q74068677 P2093 "M Talbot" @default.
- Q74068677 P2093 "M Tweed" @default.
- Q74068677 P2093 "N Wills" @default.
- Q74068677 P2093 "P D Kane" @default.
- Q74068677 P2093 "R Price" @default.
- Q74068677 P2093 "X Cockcroft" @default.
- Q74068677 P2860 Q47830170 @default.
- Q74068677 P2860 Q68157204 @default.
- Q74068677 P2860 Q73223450 @default.
- Q74068677 P304 "1567-1570" @default.
- Q74068677 P31 Q13442814 @default.
- Q74068677 P356 "10.1016/S0960-894X(00)00283-3" @default.
- Q74068677 P407 Q1860 @default.
- Q74068677 P433 "14" @default.
- Q74068677 P478 "10" @default.
- Q74068677 P577 "2000-07-01T00:00:00Z" @default.
- Q74068677 P698 "10915052" @default.
- Q74068677 P921 Q461809 @default.